Status: Current Investments

A full-service, digitally-powered pharmacy providing an easier, more supportive and more affordable pharmacy experience.

Acquired by Fuze Health in 2025

Commercial-stage life science company focused on manufacturing scalable single-use bioreactors and providing process development services to cell therapy clients.

Global contract development and manufacturing organization for radiotherapeutics.

Health prediction company utilizing proteomics and advanced statistical techniques to better predict and improve health outcomes.

Commercial-stage life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing.

Clinical-stage biotechnology company focused on enabling cures with hematopoietic stem cell therapies.

Merged with Amplitude Healthcare Acquisition Corporation in 2021

Commercial-stage specialty pharmaceutical company focused on gastrointestinal, dermatological, and women’s health products.

Clinical-stage therapeutics company focused on the central nervous system (CNS), orphan diseases, and conditions with high unmet medical need.